Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

USANA Health Sciences Operating Expenses 2010-2025 | USNA

USANA Health Sciences operating expenses from 2010 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  
USANA Health Sciences Annual Operating Expenses
(Millions of US $)
2024 $788
2023 $828
2022 $891
2021 $1,016
2020 $958
2019 $915
2018 $1,001
2017 $915
2016 $867
2015 $777
2014 $674
2013 $601
2012 $551
2011 $505
2010 $449
2009 $386
USANA Health Sciences Quarterly Operating Expenses
(Millions of US $)
2025-03-31 $234
2024-12-31 $205
2024-09-30 $185
2024-06-30 $195
2024-03-31 $203
2023-12-31 $197
2023-09-30 $196
2023-06-30 $214
2023-03-31 $222
2022-12-31 $205
2022-09-30 $211
2022-06-30 $235
2022-03-31 $240
2021-12-31 $236
2021-09-30 $234
2021-06-30 $283
2021-03-31 $264
2020-12-31 $258
2020-09-30 $253
2020-06-30 $219
2020-03-31 $228
2019-12-31 $227
2019-09-30 $225
2019-06-30 $225
2019-03-31 $238
2018-12-31 $250
2018-09-30 $251
2018-06-30 $250
2018-03-31 $249
2017-12-31 $237
2017-09-30 $230
2017-06-30 $225
2017-03-31 $222
2016-12-31 $221
2016-09-30 $218
2016-06-30 $221
2016-03-31 $207
2015-12-31 $197
2015-09-30 $195
2015-06-30 $194
2015-03-31 $190
2014-12-31 $195
2014-09-30 $163
2014-06-30 $159
2014-03-31 $157
2013-12-31 $157
2013-09-30 $149
2013-06-30 $153
2013-03-31 $143
2012-12-31 $140
2012-09-30 $141
2012-06-30 $136
2012-03-31 $133
2011-12-31 $126
2011-09-30 $125
2011-06-30 $128
2011-03-31 $126
2010-12-31 $119
2010-09-30 $116
2010-06-30 $109
2010-03-31 $105
2009-12-31 $101
2009-09-30 $99
2009-06-30 $99
2009-03-31 $87
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.550B $0.855B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.683B 31.42
Zoetis (ZTS) United States $66.251B 24.72
Daiichi Sankyo, - (DSNKY) Japan $46.431B 23.80
Takeda Pharmaceutical (TAK) Japan $43.274B 8.83
BeOne Medicines - (ONC) Cayman Islands $32.874B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.885B 0.00
Summit Therapeutics (SMMT) United States $19.799B 0.00
Merck (MKKGY) Germany $16.472B 12.07
Shionogi (SGIOY) Japan $14.326B 14.35
Neurocrine Biosciences (NBIX) United States $13.535B 40.46
United Therapeutics (UTHR) United States $12.718B 11.01
Orion OYJ (ORINY) Finland $11.482B 27.67
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.553B 46.19
Grifols, S.A (GRFS) Spain $7.460B 0.00
Corcept Therapeutics (CORT) United States $7.414B 60.27
Ionis Pharmaceuticals (IONS) United States $6.903B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.436B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.277B 0.00
Hypermarcas (HYPMY) Brazil $3.066B 20.17
Crinetics Pharmaceuticals (CRNX) United States $2.737B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.596B 9.09
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.529B 13.68
NewAmsterdam Pharma (NAMS) Netherlands $2.518B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.213B 0.00
Ocular Therapeutix (OCUL) United States $1.857B 0.00
Endo (NDOI) United States $1.763B 0.00
ARS Pharmaceuticals (SPRY) United States $1.756B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.720B 0.00
Evotec AG (EVO) Germany $1.481B 0.00
Dyne Therapeutics (DYN) United States $1.410B 0.00
Guardian Pharmacy Services (GRDN) United States $1.296B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.223B 24.46
Harrow (HROW) United States $1.199B 0.00
Ardelyx (ARDX) United States $1.038B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.035B 0.00
Collegium Pharmaceutical (COLL) United States $0.986B 5.32
Akebia Therapeutics (AKBA) United States $0.961B 0.00
Enliven Therapeutics (ELVN) United States $0.948B 0.00
Xeris Biopharma Holdings (XERS) United States $0.802B 0.00
ProKidney (PROK) United States $0.787B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.691B 0.00
Relay Therapeutics (RLAY) United States $0.622B 0.00
Xencor (XNCR) United States $0.621B 0.00
Zevra Therapeutics (ZVRA) United States $0.601B 0.00
Tourmaline Bio (TRML) United States $0.600B 0.00
Organogenesis (ORGO) United States $0.591B 0.00
Elite Pharmaceuticals (ELTP) United States $0.563B 0.00
Theravance Biopharma (TBPH) United States $0.554B 0.00
Bioventus (BVS) United States $0.537B 13.62
Oruka Therapeutics (ORKA) United States $0.516B 0.00
Siga Technologies (SIGA) United States $0.477B 9.96
Savara (SVRA) United States $0.442B 0.00
Aquestive Therapeutics (AQST) United States $0.389B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.376B 10.15
AleAnna (ANNA) United States $0.347B 0.00
Nanobiotix S.A (NBTX) France $0.315B 0.00
Aldeyra Therapeutics (ALDX) United States $0.302B 0.00
Altimmune (ALT) United States $0.296B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.284B 0.00
Esperion Therapeutics (ESPR) United States $0.279B 0.00
Nektar Therapeutics (NKTR) United States $0.274B 0.00
Heron Therapeutics (HRTX) United States $0.273B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.42
OmniAb (OABI) United States $0.238B 0.00
Larimar Therapeutics (LRMR) United States $0.229B 0.00
Galectin Therapeutics (GALT) United States $0.228B 0.00
MediWound (MDWD) Israel $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.204B 0.00
Lyell Immunopharma (LYEL) United States $0.184B 0.00
China SXT Pharmaceuticals (SXTC) China $0.178B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Liminatus Pharma (LIMN) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.154B 0.00
Korro Bio (KRRO) United States $0.153B 0.00
Avita Medical (RCEL) United States $0.142B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.135B 0.00
Protara Therapeutics (TARA) United States $0.123B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Achieve Life Sciences (ACHV) Canada $0.093B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Champions Oncology (CSBR) United States $0.088B 20.03
Metagenomi (MGX) United States $0.085B 0.00
Vivani Medical (VANI) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Surrozen (SRZN) United States $0.080B 0.00
Nutriband (NTRB) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Context Therapeutics (CNTX) United States $0.073B 0.00
Avalo Therapeutics (AVTX) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Inotiv (NOTV) United States $0.071B 0.00
Wellgistics Health (WGRX) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.065B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
DURECT (DRRX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
BioNxt Solutions (BNXTF) Canada $0.053B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 38.22
Century Therapeutics (IPSC) United States $0.049B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Mural Oncology (MURA) Ireland $0.040B 0.00
Enlivex Therapeutics (ENLV) Israel $0.036B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
FibroGen (FGEN) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.028B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Vivos Therapeutics (VVOS) United States $0.027B 0.00
Incannex Healthcare (IXHL) Australia $0.026B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
Scienture Holdings (SCNX) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
CASI Pharmaceuticals (CASI) China $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Carisma Therapeutics (CARM) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.33
TherapeuticsMD (TXMD) United States $0.013B 0.00
BioVie (BIVI) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 10.18
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00